Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Decibel Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −1 vs. Q4 2021
- Shares held
- 17.7M
- +131.9K (+0.8%) vs. Q4 2021
- Total value
- $53.8M
- −$27.9M (−34.1%) vs. Q4 2021
- New holders
- 4
- 9 more added
- Sold out
- 5
- 9 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DBTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $36.4K |
| Q3 2023 | 1 | $36.4K |
| Q2 2023 | 37 | $59.2M |
| Q1 2023 | 38 | $46.7M |
| Q4 2022 | 39 | $35.8M |
| Q3 2022 | 40 | $62.1M |
| Q2 2022 | 42 | $75.2M |
| Q1 2022 | 39 | $53.8M |
| Q4 2021 | 40 | $81.7M |
| Q3 2021 | 36 | $145.9M |
| Q2 2021 | 46 | $168.1M |
| Q1 2021 | 54 | $226.3M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Decibel Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Financial Connections Group, Inc. | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 694 | $2.00K | 0.00% | −715−50.7% | Reduced |
| Citigroup Inc | 531 | $2.00K | 0.00% | −220−29.3% | Reduced |
| FNY Investment Advisers, LLC | 3,200 | $9.00K | 0.01% | +3,200 | New |
| Acadian Asset Management LLC | 4,283 | $13.0K | 0.00% | 00.0% | Unchanged |
| Flagship Harbor Advisors, LLC | 10,113 | $31.0K | 0.00% | 00.0% | Unchanged |
| Laurion Capital Management LP | 11,990 | $36.0K | 0.00% | −3,063−20.3% | Reduced |
| Northern Trust Corp | 14,239 | $43.0K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 15,000 | $46.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 16,260 | $49.0K | 0.00% | +560+3.6% | Added |
| Susquehanna International Group, LLP | 16,846 | $51.0K | 0.00% | −22,580−57.3% | Reduced |
| Bank of America Corp | 18,689 | $56.0K | 0.00% | +4,966+36.2% | Added |
| Bailard, Inc. | 19,700 | $60.0K | 0.00% | +19,700 | New |
| MYDA Advisors LLC | 20,000 | $61.0K | 0.03% | +20,000 | New |
| Renaissance Technologies LLC | 20,915 | $64.0K | 0.00% | −29,985−58.9% | Reduced |
| Two Sigma Investments, LP | 22,308 | $68.0K | 0.00% | −25,060−52.9% | Reduced |
| Morgan Stanley | 22,841 | $69.0K | 0.00% | +9,579+72.2% | Added |
| Marquette Asset Management, LLC | 25,704 | $78.0K | 0.02% | +7,232+39.2% | Added |
| Bank of New York Mellon Corp | 27,310 | $83.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 39,074 | $119.0K | 0.00% | +418+1.1% | Added |
| Atlas Capital Advisors LLC | 41,025 | $124.7K | 0.02% | 00.0% | Unchanged |
| Neuberger Berman Group LLC | 62,825 | $191.0K | 0.00% | +3,255+5.5% | Added |
| Geode Capital Management, LLC | 69,283 | $210.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 114,928 | $349.0K | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 156,369 | $476.0K | 0.00% | −4,156−2.6% | Reduced |
| Bronte Capital Management Pty Ltd. | 163,224 | $496.0K | 0.07% | +6,008+3.8% | Added |
| Barclays PLC | 240,337 | $731.0K | 0.00% | +240,337 | New |
| Suvretta Capital Management, LLC | 263,600 | $801.0K | 0.02% | 00.0% | Unchanged |
| Woodline Partners LP | 275,001 | $836.0K | 0.01% | 00.0% | Unchanged |
| Harvard Management Co Inc | 328,798 | $1.00M | 0.10% | 00.0% | Unchanged |
| Casdin Capital, LLC | 330,000 | $1.00M | 0.04% | −840,048−71.8% | Reduced |
| Bessemer Group Inc | 494,071 | $1.50M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 622,937 | $1.89M | 0.00% | −1,860−0.3% | Reduced |
| Samsara BioCapital, LLC | 826,422 | $2.51M | 0.64% | 00.0% | Unchanged |
| Alphabet Inc. | 1,636,258 | $4.97M | 0.16% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,773,691 | $5.39M | 0.01% | +1300.0% | Added |
| BlackRock Inc. | 1,897,223 | $5.77M | 0.00% | +801,010+73.1% | Added |
| TRV GP III, LLC | 3,139,685 | $9.54M | 2.59% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,945,192 | $15.0M | 0.24% | 00.0% | Unchanged |
| FMR LLC | 0 | $0 | 0.00% | −43,500−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,300−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −867−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1,075−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −95−100.0% | Sold out |